MedPath

Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

FDA:4

Drug Approvals

Risedronate Sodium

Approval Date
Nov 16, 2023
FDA

Alendronate

Approval Date
Nov 12, 2023
FDA

Tamsulosin Hydrochloride

Approval Date
May 26, 2020
FDA

Montelukast Sodium

Approval Date
Nov 12, 2015
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.